Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
56,251,498
-
Shares change
-
+7,801,632
-
Total reported value, excl. options
-
$754,888,970
-
Value change
-
+$105,637,327
-
Put/Call ratio
-
87%
-
Number of buys
-
75
-
Number of sells
-
-60
-
Price
-
$13.42
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2018
148 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q2 2018.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,251,498 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,917,700 shares), BlackRock Inc. (4,054,285 shares), Redmile Group, LLC (2,957,765 shares), PERCEPTIVE ADVISORS LLC (2,742,821 shares), VANGUARD GROUP INC (2,679,199 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,475,000 shares), FMR LLC (2,415,837 shares), BOXER CAPITAL, LLC (2,094,000 shares), EAGLE ASSET MANAGEMENT INC (2,063,066 shares), and Foresite Capital Management IV, LLC (2,023,369 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.